NC

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$5.3B
AUM Growth
+$423M
Cap. Flow
+$190M
Cap. Flow %
3.57%
Top 10 Hldgs %
29.77%
Holding
244
New
8
Increased
67
Reduced
55
Closed
21
Avg Time Held
1.4 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
PAGP icon
Plains GP Holdings
PAGP
+$92M
2
ABBV icon
AbbVie
ABBV
+$74.1M
3
SLH
SOLERA HOLDINGS, INC. COM
SLH
+$59.3M
4
GILD icon
Gilead Sciences
GILD
+$39.4M
5
MCD icon
McDonald's
MCD
+$27M

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$61M
2
MTD icon
Mettler-Toledo International
MTD
+$36.5M
3
SENEA icon
Seneca Foods Class A
SENEA
+$23.9M
4
ORLY icon
O'Reilly Automotive
ORLY
+$15.9M
5
WBA icon
Walgreens Boots Alliance
WBA
+$15.7M

Sector Composition

Rank Sector Weight
1 Healthcare 27.62%
2 Industrials 17.64%
3 Consumer Discretionary 15.61%
4 Financials 10.97%
5 Technology 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BHC icon
1
Bausch Health
BHC
$2.2B
$269M 5.07%
1,354,455
-515
-0% -$91.4K
2013 Q2
7 quarters
WBA icon
2
DELISTED
Walgreens Boots Alliance
WBA
$185M 3.5%
2,190,450
-197,565
-8% -$15.7M
2013 Q2
7 quarters
GILD icon
3
Gilead Sciences
GILD
$190B
$184M 3.48%
1,879,035
+388,370
+26% +$39.4M
2013 Q2
7 quarters
AMG icon
4
Affiliated Managers Group
AMG
$9.62B
$169M 3.18%
784,600
+31,025
+4% +$6.55M
2013 Q2
7 quarters
SNA icon
5
Snap-on
SNA
$18.8B
$135M 2.54%
915,725
-810
-0.1% -$114K
2013 Q2
7 quarters
TMO icon
6
Thermo Fisher Scientific
TMO
$249B
$132M 2.49%
982,590
-351
-0% -$45.2K
2013 Q2
7 quarters
KMI icon
7
Kinder Morgan
KMI
$74.3B
$129M 2.44%
3,071,789
+200,198
+7% +$8.29M
2013 Q2
7 quarters
ORLY icon
8
O'Reilly Automotive
ORLY
$70.1B
$128M 2.41%
8,875,830
-1,183,155
-12% -$15.9M
2013 Q2
7 quarters
ADT icon
9
DELISTED
ADT Corp
ADT
$124M 2.34%
2,988,445
-79,870
-3% -$3M
2014 Q2
3 quarters
AON icon
10
Aon
AON
$58.4B
$124M 2.33%
1,286,940
-7,580
-0.6% -$733K
2013 Q2
7 quarters
TGNA icon
11
DELISTED
TEGNA Inc
TGNA
$116M 2.2%
6,005,589
+439
+0% +$7.75K
2013 Q2
7 quarters
CBRE icon
12
CBRE Group
CBRE
$37.3B
$116M 2.19%
3,004,040
– –
2013 Q2
7 quarters
LKQ icon
13
LKQ Corp
LKQ
$5.52B
$106M 2%
4,158,907
+598,895
+17% +$15.5M
2013 Q2
7 quarters
BALL icon
14
Ball Corp
BALL
$16B
$106M 2%
3,005,652
-50
-0% -$1.73K
2013 Q2
7 quarters
DVA icon
15
DaVita
DVA
$11.5B
$98.5M 1.86%
1,211,318
-5,730
-0.5% -$440K
2013 Q2
7 quarters
MSFT icon
16
Microsoft
MSFT
$3.96T
$97.6M 1.84%
2,401,070
+38,100
+2% +$1.66M
2013 Q2
7 quarters
PFE icon
17
Pfizer
PFE
$166B
$96.3M 1.82%
2,918,832
+606
+0% +$19.3K
2013 Q2
7 quarters
PAGP icon
18
Plains GP Holdings
PAGP
$5.37B
$95.7M 1.8%
+1,266,842
New +$92M
2015 Q1
0 quarters
JCI icon
19
Johnson Controls International
JCI
$92.3B
$91.8M 1.73%
1,737,336
+191
+0% +$9.71K
2013 Q4
5 quarters
CB icon
20
Chubb
CB
$135B
$86.4M 1.63%
775,070
-25
-0% -$2.81K
2014 Q1
4 quarters
TWX
21
DELISTED
Time Warner Inc
TWX
$82.4M 1.55%
976,370
+290,615
+42% +$24.1M
2013 Q2
7 quarters
CPRT icon
22
Copart
CPRT
$24.3B
$82.3M 1.55%
17,532,720
-280
-0% -$1.3K
2013 Q2
7 quarters
PII icon
23
Polaris
PII
$2.88B
$81.6M 1.54%
578,194
-10
-0% -$1.47K
2013 Q2
7 quarters
PM icon
24
Philip Morris
PM
$320B
$81.5M 1.54%
1,081,560
+149,975
+16% +$12.2M
2013 Q2
7 quarters
PCP
25
DELISTED
PRECISION CASTPARTS CORP
PCP
$78.5M 1.48%
373,805
– –
2014 Q4
1 quarter
1
2 3 4 5

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q1 2015 Portfolio in Review

As of Q1 2015, Nicholas Company held 244 positions worth $5.3B, up 8.7% from $4.88B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nicholas Company deployed $190M of net new capital in Q1 2015, opening 8 new positions and adding to 67 existing holdings. Its largest new stake was Plains GP Holdings: 1,266,842 shares worth $95.7M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was O'Reilly Automotive, an estimated $15.9M trimmed.

  • Nicholas Company's largest Q1 2015 buy was Plains GP Holdings: 1,266,842 shares worth $95.7M.
  • Nicholas Company added most to Gilead Sciences in Q1 2015, an estimated $39.4M increase.
  • Nicholas Company's biggest Q1 2015 reduction was O'Reilly Automotive, cutting an estimated $15.9M.
  • Nicholas Company fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $61M.
  • Nicholas Company's ten largest holdings make up 30% of its $5.3B portfolio in Q1 2015.
  • Nicholas Company opened 8 new positions and closed 21 in Q1 2015.
  • Nicholas Company's portfolio value rose 8.7% quarter-over-quarter to $5.3B.

Based on Nicholas Company's 13F filing for Q1 2015, filed 13 May 2015.